Drupal.behaviors.print = function(context) {window.print();window.close();}>
CML HealthCare Licenses Phenomenome Cancer Tests
April 11, 2011
CML HealthCare Licenses Phenomenome Cancer Tests
The firm has developed a metabolomic biomarker-based test for colorectal cancer.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Phenomenome, Polymedco Ink Pact to Commercialize Mass Spec-based Colorectal Cancer Test
June 28, 2012 / GenomeWeb Daily News
Epigenomics Licenses Septin9 Biomarker to Companion Dx Lab for Colorectal Cancer Test
June 19, 2012 / GenomeWeb Daily News
BioChain Licenses Epigenomics Methylation Marker
March 7, 2013 / GenomeWeb Daily News
Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News
Empire Genomics Licenses Biomarker from Emory University for Multiple Myeloma CDx
November 29, 2012 / GenomeWeb Daily News